Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Berk

Showing results (581-590 of 1,136) with videos related to

Pageof 114
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 2021
Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disordersGerwyn Morris, Ken Walder, Michael Berk, et al.
Molecular Neurobiology|March 29, 2022
Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and SchizophreniaGerwyn Morris, Luba Sominsky, Kenneth R Walder, et al.
Bipolar Disorders|August 20, 2009
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatmentsFelicity Ng, Oommen K Mammen, Ingeborg Wilting, et al.
Neuroscience and Biobehavioral Reviews|April 26, 2017
The effect of N-acetylcysteine (NAC) on human cognition - A systematic reviewDavid R Skvarc, Olivia M Dean, Linda K Byrne, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2008
Tobacco smoking as a risk factor for major depressive disorder: population-based studyJulie A Pasco, Lana J Williams, Felice N Jacka, et al.
Early Intervention in Psychiatry|March 26, 2021
Personality disorder among youth with first episode psychotic mania: An important target for specific treatment?Melissa K Hasty, Craig A Macneil, Sue M Cotton, et al.
Redox Report : Communications in Free Radical Research|March 3, 2015
N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot studyEduardo Prado, Michael Maes, Luiz Gustavo Piccoli, et al.
International Clinical Psychopharmacology|February 28, 2008
Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depressionLana J Williams, Margaret J Henry, Michael Berk, et al.
Journal of Integrative Medicine|February 8, 2024
Predictors of the placebo response in a nutraceutical randomized controlled trial for depressionRosemary Arnold, Jenifer Murphy-Smith, Chee H Ng, et al.
JAMA Network Open|September 15, 2023
Bipolar At-Risk Criteria and Risk of Bipolar Disorder Over 10 or More YearsAswin Ratheesh, Dylan Hammond, Michael Watson, et al.
Pageof 114

Showing results (581-590 of 1,136) with videos related to

Sort By:
Pageof 114
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 2021
Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disordersGerwyn Morris, Ken Walder, Michael Berk, et al.
Molecular Neurobiology|March 29, 2022
Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and SchizophreniaGerwyn Morris, Luba Sominsky, Kenneth R Walder, et al.
Bipolar Disorders|August 20, 2009
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatmentsFelicity Ng, Oommen K Mammen, Ingeborg Wilting, et al.
Neuroscience and Biobehavioral Reviews|April 26, 2017
The effect of N-acetylcysteine (NAC) on human cognition - A systematic reviewDavid R Skvarc, Olivia M Dean, Linda K Byrne, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2008
Tobacco smoking as a risk factor for major depressive disorder: population-based studyJulie A Pasco, Lana J Williams, Felice N Jacka, et al.
Early Intervention in Psychiatry|March 26, 2021
Personality disorder among youth with first episode psychotic mania: An important target for specific treatment?Melissa K Hasty, Craig A Macneil, Sue M Cotton, et al.
Redox Report : Communications in Free Radical Research|March 3, 2015
N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot studyEduardo Prado, Michael Maes, Luiz Gustavo Piccoli, et al.
International Clinical Psychopharmacology|February 28, 2008
Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depressionLana J Williams, Margaret J Henry, Michael Berk, et al.
Journal of Integrative Medicine|February 8, 2024
Predictors of the placebo response in a nutraceutical randomized controlled trial for depressionRosemary Arnold, Jenifer Murphy-Smith, Chee H Ng, et al.
JAMA Network Open|September 15, 2023
Bipolar At-Risk Criteria and Risk of Bipolar Disorder Over 10 or More YearsAswin Ratheesh, Dylan Hammond, Michael Watson, et al.
Pageof 114